학술논문
Chemotherapy plus involved-field radiation in early-stage Hodgkin's disease
Document Type
Clinical report
Author
Ferme, Christophe; Eghbali, Houchingue; Meerwaldt, Jacobus H.; Rieux, Chantal; Bosq, Jacques; Berger, Francoise; Girinsky, Theodore; Brice, Pauline; van't Veer, Mars B.; Walewski, Jan A.; Lederlin, Pierre; Tirelli, Umberto; Carde, Patrice; Van Den, Neste, Eric; Gyan, Emmanuel; Divine, Marine; Raemaekers, John M.M.; Salles, Gilles; Noordijk, Evert M.; Creemers, Geert-Jan; Gabarre, Jean; Hagenbeek, Anton; Reman, Oumedaly; Blanc, Michel; Thomas, Jose; Brigitte Vie; Kluin-Nelemans, Johanna C.; Viseu, Fernando; Baars, Joke W.; Poortmans, Philip; Lugtenburg, Pieternella J.; Carrie, Christian; Jaubert, Jerome; Henry-Amar, Michel
Source
The New England Journal of Medicine. Nov 8, 2007, Vol. 357 Issue 19, p1916, 12 p.
Subject
Language
English
ISSN
0028-4793
Abstract
The results from trials of patients with favorable prognostic features of Hodgkin's disease are reported. Chemotherapy plus involved-field radiotherapy was found to be superior to subtotal nodal radiotherapy as standard therapy while limited chemotherapy was effective for unfavorable patients.